Quotables
"There is practically no chance communications space satellites will be used to provide better telephone, telegraph, television, or radio service inside the United States."
T. Craven, FCC Commissioner ; 1961
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120046367 | ESSENTIAL OIL COMPOSITION WITH ANTI-FREE RADICAL ABILITY Disclosed is an essential oil composition with anti-free radical ability, which includes dl-Citronellol, Eugenol, cis/trans-Citral, Eugenol Methyl Ether and Thymol. It is confirmed that the essential oil composition of the present invention has superior anti-free radica... | 02/23/2012 |
| 20120041073 | STABILIZED MUTANT OPSIN PROTEINS Methods and compositions for stabilizing opsin protein in a vertebrate visual system are provided by administration of opsin-binding synthetic retinoids.... | 02/16/2012 |
| 20120034288 | COMPOSITIONS AND METHODS FOR ENHANCED ATTRACTION OF NOCTUID MOTHS The invention provides compositions for attracting noctuid moths, which include at least one pheromone and at least one enhancer. The enhancer is a naturally-occurring phytochemical compound. The enhancer is preferably trans-2, cis-6-nonadienal. The invention also provi... | 02/09/2012 |
| 20120009255 | METHODS OF TREATING INFECTIOUS DISEASES The present invention provides methods of treating a human or other mammal infected with a parasitic microorganism by administering an effective amount in unit dosage form of a C8-C16-alpha, beta-unsaturated aliphatic aldehyde, such as trans-2-dode... | 01/12/2012 |
| 20120003181 | Novel Retinoid Inducible Factor and Uses Thereof The present invention describes a novel retinoid-responsive nucleic acid, and a novel protein. Further, the invention describes the use of such a nucleic acid or protein in various diseases, and for the treatment, the diagnosis and prognosis of various diseases, and als... | 01/05/2012 |
| 20110257255 | COMPOSITION AND METHOD FOR INHIBITION OF NERVE TRANSMISSION The presently claimed and disclosed invention(s) provides a therapeutically effective composition and method of inhibiting nerve cell transmission. In a preferred embodiment of the presently claimed and disclosed invention(s), the treatment of neuropathic pain utilizing... | 10/20/2011 |
| 20110244062 | MULTIPLICATION OF THE EFFICACY OF ANTI-INFECTIOUS AGENTS BY A COMPOSITION COMPRISING AN EXTRACT MADE FROM DEHYDRATED AND PARTIALLY SODIUM-FREE SEAWATER The present invention relates to a composition inhibiting or destroying at least one living or unicellular organism, which comprises at least one anti-infectious agent and one activating agent, which consists of an extract made from dehydrated and partially sodium-free ... | 10/06/2011 |
| 20110245307 | Methods for Alzheimer's Disease Treatment and Cognitive Enhancement The present invention relates to compositions comprising a combination of PKC activators and PKC inhibitors and methods to modulate α-secretase activity; improve or enhance cognitive ability; and/or reduce neurodegeneration in individuals suffering from diseases that i... | 10/06/2011 |
| 20110218245 | USE OF COMPOUNDS TO INHIBIT 5A-REDUCTASE ENZYME ACTIVITY, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM The object of the present invention is the use of compounds designed to inhibit the activity of the enzyme 5α-reductase. This is a novel use of compounds of general formula (I):
| |
| 20110206626 | Method for Treating Skin with Booster Compositions A skin care product comprising from about 0.001% to about 10% of a retinoid, in combination with 0.0001% to about 50% of a combination of retinoid boosters.... | 08/25/2011 |
| 20110151029 | Paxillin Stimulating Compositions and Cosmetic Uses Thereof Cosmetic compositions comprising one or more paxillin stimulators and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. The paxillin stimulators and combinations thereof are believed to have modulatory activity against at least ... | 06/23/2011 |
| 20110142771 | Photostabilization of Retinoids with Alkoxycrylene Compounds The photostabilizing electronic excited state energy—particularly singlet state energy from retinoid compounds—has been found to be readily transferred to (accepted by) α-cyanodiphenylacrylate compounds having an alkoxy radical in the four (para) position (hereinaf... | 06/16/2011 |
| 20110136918 | Methods of Treating Infectious Diseases The present invention provides methods of treating a human or other mammal infected with a parasitic microorganism by administering an effective amount in unit dosage form of a C8-C16-alpha, beta-unsaturated aliphatic aldehyde, such as trans-2-dode... | 06/09/2011 |
| 20110059159 | NANOSCALE BOUND BILAYERS, METHODS OF USE AND PRODUCTION Methods for rapidly obtaining a nanoscale apolipoprotein bound phospholipid bilayer (NABB) associated with at least one membrane protein are provided. Also disclosed are methods for rapidly obtaining a NABB not associated with membrane proteins. Immunogenic compositions... | 03/10/2011 |
| 20110046234 | Retinaldehyde in the Treatment of Obesity, Diabetes and Other Conditions The present invention is directed to methods of treating a patient for a disease or condition associated with adipogenesis or insulin resistance by administering a retinaldehyde compound to the patient or a compound that increases endogenous retinaldehyde levels by inhi... | 02/24/2011 |
| 20110034554 | COMPOSITIONS AND METHODS FOR TREATING MACULAR DEGENERATION Methods of retarding formation of a lipofuscin pigment in the retina and of treating or ameliorating the effects of a disease characterized by an accumulation of a lipofuscin pigment in a retina are provided. These methods include the step of administering to a patient ... | 02/10/2011 |
| 20110009333 | PHARMACEUTICAL OR COSMETIC COMPOSITION AND USE OF A PKC INHIBITOR WITH AN MMP INHIBITOR FOR INHIBITING LANGERHANS' CELL MIGRATION Disorders of the skin or mucous membranes which are linked to migration of Langerhans cells are treated by the administration of an effective amount of at least one retinoid, optionally in combination with a PKC inhibitor.... | 01/13/2011 |
| 20100273801 | BETULIN DERIVED COMPOUNDS USEFUL AS ANTIBACTERIAL AGENTS The invention relates to compouns derived from betulin, and to the use thereof as antibacterial agents in pharmaceutical and cosmetic applications.... | 10/28/2010 |
| 20100272818 | COMPOSITIONS AND METHODS COMPRISING TERPENES OR TERPENE MIXTURES SELECTED FROM THYMOL, EUGENOL, GERANIOL, CITRAL, AND L-CARVONE The present invention relates to compositions comprising terpenes which are particularly suitable for treating plant infections, to methods of making such compositions, and to methods of using them. The present invention also relates to compositions comprising terpenes ... | 10/28/2010 |
| 20100189818 | SORBIC AND BENZOIC ACID AND DERIVATIVES THEREOF ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL Methods and compositions are provided for treating neuropsychiatric disorders such as schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, and bipolar disorder. The methods entail administering to a patient diagnosed as having a ne... | 07/29/2010 |
| 20100168231 | TARGET ENZYME FOR THE TREATMENT OF ACNE The use of an enzyme as a research tool for acne, by identifying a compound for the treatment of acne and/or any disorder associated with cutaneous hyperseborrhoea.... | 07/01/2010 |
| 20100136102 | TERPENE-CONTAINING COMPOSITIONS AND METHODS OF MAKING AND USING THEM The present invention relates to compositions comprising terpenes and hollow glucan particles or cell wall particles and methods for preparing such compositions. The compositions increase terpene stability and activity and provide a suitable carrier for the terpenes. Th... | 06/03/2010 |
| 20100136108 | FORMULATION FOR RETINOID-CONTAINING SOFT GELATIN CAPSULES A new pharmaceutical formulation for retinoid-containing soft gelatin capsules is disclosed. The new formulation comprises a soft gelatin capsule filled with a fill mass comprising a retinoid as an active ingredient, a natural vegetable oil, a partially hydrogenated nat... | 06/03/2010 |
| 20100120911 | PRESERVATIVE SYSTEM FOR COSMETIC FORMULATIONS Disclosed is a novel method for preserving cosmetic/personal care formulations through a two component preservative system, said system comprising (a) Component I which functions to eliminate the existing microbial contamination load in a natural cosmetic formulation ba... | 05/13/2010 |
| 20100104644 | Compositions and Methods for Treating or Preventing Ophthalmic Disease Methods are disclosed for treating or preventing ophthalmic conditions related to a toxic visual cycle product. Compounds and compositions useful in these methods, either alone or in combination with other therapeutic agents, are also described, along with methods of sc... | 04/29/2010 |
| 20100034907 | DISINFECTANT FORMULATION An aqueous disinfectant formulation comprising at least one phenolic compound of natural origin; a surfactant sufficient to form a solution or dispersion of the essential oil in an aqueous carrier; a solvent, and sufficient water to make 100 weight percent is described ... | 02/11/2010 |
| 20100035986 | METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION A method of treating or preventing age-related retinal dysfunction involves administering to a patient a pharmaceutically effective amount of a synthetic retinal derivative repeatedly over a duration of at least about 3 months. Effective synthetic retinal derivatives in... | 02/11/2010 |
| 20100028464 | USE OF SAFFRON AND/OR SAFRANAL AND/OR CROCIN AND/OR PICROCROCIN AND/OR DERIVATIVES THEREOF AS A SATEITY AGENT FOR TREATMENT OF OBESITY Use of saffron and its active ingredients, such as safranal and/or picrocrocin and/or crocin and/or derivatives thereof, for the production of an active satiation agent for the treatment of problems of overweight.... | 02/04/2010 |
| 20090324570 | Photostabilization of Retinoids with Alkoxycrylene Compounds The photostabilizing electronic excited state energy—particularly singlet state energy from retinoid compounds—has been found to be readily transferred to (accepted by) α-cyanodiphenylacrylate compounds having an alkoxy radical in the four (para) position (hereinaf... | 12/31/2009 |
| 20090258098 | PENETRATING CARRIER, ANTIFUNGAL COMPOSITION USING THE SAME AND METHOD FOR TREATMENT OF DERMATOPHYTE INFECTIONS An antifungal composition and penetrating carrier system for topical treatment of dermatophytic infection and secondary bacterial infections. The antifungal composition includes various fungistatic and fungicidal essential oil components, or combinations thereof. The pe... | 10/15/2009 |
| 20090214504 | Methods and Compositions for Topical Treatment of Medical Conditions Including Wounds and Inflammation A method for treating a patient suffering from a wound, ulcer, or inflammation includes providing a topical formulation comprising a carrier and a combination of active ingredients that includes at least one retinoid and at least one blood vessel dilator, and applying t... | 08/27/2009 |
| 20090197939 | METHODS OF TREATING SKIN WITH AROMATIC SKIN-ACTIVE INGREDIENTS A method for treating skin, reducing oxidative damage to a skin cell, reducing lipoxygenase (LO) activity in a skin cell, reducing cyclooxygenase (COX) activity in a skin cell, reducing tumor necrosis factor alpha (TNF-α) in a skin cell, or reduction matrix metalloprot... | 08/06/2009 |
| 20090047342 | Methods of Treating Infectious Diseases The present invention provides methods of treating a human or other mammal infected with a parasitic microorganism by administering an effective amount in unit dosage form of a C8-C16-alpha, beta-unsaturated aliphatic aldehyde, such as trans-2-dode... | 02/19/2009 |
| 20090030055 | PKC activation as a means for enhancing sAPPALPHA secretion and improving cognition using bryostatin type compounds The present invention relates to compositions and methods to modulate α-secretase and/or to improve cognitive ability. The invention further relates the improved/enhanced cognitive ability in diseased individuals, particularly Alzheimer's Disease patients, and treatmen... | 01/29/2009 |
| 20090018212 | METHODS OF RELIEVING STRESS Methods, combinations and compositions for relieving or preventing the effects of stress are provided. In particular, combinations and compositions comprising cis-3-hexen-1-ol, trans-2-hexenal and α-pinene, articles of manufacture impregnated with the combination or co... | 01/15/2009 |
| 20080312087 | 2-Propenal and Related Enal Compounds for Controlling Plant Pests and Weeds in Soil A method for controlling pests and weeds on or around plants, especially crop plants is disclosed. The method includes admixing 2-propenal or other related enal compounds to form an aqueous solution, and applying the aqueous solution to plants, plant seeds, weeds, or so... | 12/18/2008 |
| 20080274169 | Photosensitizer formulations for topical applications Highly flexible penetrating liposomal carrier systems are formulated with enhanced skin penetration properties. These specialized formulations of highly flexible penetrating liposomal delivery systems comprise one or more phospholipids, lysophosphatides and hydrophobic ... | 11/06/2008 |
| 20080249197 | Process for the Production of Methanol from Methane using a Supported Transition Metal Catalyst A process for the selective oxidation of methane to methanol using a supported transition metal catalyst has been developed. Examples of the transition metals which can be used are copper and palladium, while an example of a support is silica. Optionally, the catalyst c... | 10/09/2008 |
| 20080220038 | Nematicidal Compositions and Methods of Using Them There is disclosed method of killing nematodes comprising the step of applying an effective amount of a nematicidal composition comprising a terpene component and compositions suitable for use in the method. The terpene component is preferably in association with water,... | 09/11/2008 |
| 20080145409 | COMPOSITION FOR THE TREATMENT AND PREVENTION OF PEPTIC ULCER The present invention relates to a composition and methods of administering the composition, comprising Citronellol and its analogues and derivatives, to humans and other mammalian animals with peptic ulcers induced by alcohol consumption, H. pylori infection, st... | 06/19/2008 |
